Lipocine Inc.
LPCN
$7.67
$0.385.21%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 899.48% | -81.60% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 899.48% | -81.60% | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | 899.48% | -81.60% | |||
| SG&A Expenses | 28.08% | -13.77% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 5.34% | 14.81% | |||
| Operating Income | 25.15% | -39.79% | |||
| Income Before Tax | 25.63% | -44.48% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 25.63% | -44.48% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 25.63% | -44.48% | |||
| EBIT | 25.15% | -39.79% | |||
| EBITDA | 25.28% | -40.14% | |||
| EPS Basic | 29.13% | -42.85% | |||
| Normalized Basic EPS | 29.16% | -42.86% | |||
| EPS Diluted | 29.12% | -43.17% | |||
| Normalized Diluted EPS | 29.16% | -42.86% | |||
| Average Basic Shares Outstanding | 4.95% | 1.14% | |||
| Average Diluted Shares Outstanding | 4.95% | 1.14% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||